...
首页> 外文期刊>Cell >Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling
【24h】

Limiting Cholesterol Biosynthetic Flux Spontaneously Engages Type I IFN Signaling

机译:限制胆固醇生物合成助焊剂自发地接合I型IFN信号传导

获取原文
获取原文并翻译 | 示例
           

摘要

Cellular lipid requirements are achieved through a combination of biosynthesis and import programs. Using isotope tracer analysis, we show that type I interferon (IFN) signaling shifts the balance of these programs by decreasing synthesis and increasing import of cholesterol and long chain fatty acids. Genetically enforcing this metabolic shift in macrophages is sufficient to render mice resistant to viral challenge, demonstrating the importance of reprogramming the balance of these two metabolic pathways in vivo. Unexpectedly, mechanistic studies reveal that limiting flux through the cholesterol biosynthetic pathway spontaneously engages a type I IFN response in a STING-dependent manner. The upregulation of type I IFNs was traced to a decrease in the pool size of synthesized cholesterol and could be inhibited by replenishing cells with free cholesterol. Taken together, these studies delineate a metabolic-inflammatory circuit that links perturbations in cholesterol biosynthesis with activation of innate immunity.
机译:通过生物合成和进口程序的组合实现细胞脂质要求。使用同位素跟踪分析,我们表明I型干扰素(IFN)信号传导通过降低胆固醇和长链脂肪酸的合成和进口量来移动这些程序的平衡。基因上实施这种巨噬细胞的这种代谢移足就足以使小鼠对病毒攻击进行抗性,证明重新编程在体内这两个代谢途径的平衡的重要性。意外地,机械研究揭示了通过胆固醇生物合成途径的限制通量自发地以鉴别依赖性方式与I型IFN响应接合。 I型IFNS的上调被追踪到合成胆固醇的池尺寸的减少,并且可以通过用游离胆固醇补充细胞来抑制。总之,这些研究描绘了一种代谢炎症回路,其在胆固醇生物合成中与先天免疫激活联系起来。

著录项

  • 来源
    《Cell》 |2015年第7期|共14页
  • 作者单位

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles Dept Microbiol Immunol &

    Mol Genet Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Human Genet Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Div Hematol Oncol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles Dept Microbiol Immunol &

    Mol Genet Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Div Cardiol Los Angeles CA 90095 USA;

    Massachusetts Gen Hosp Dept Radiol Ctr Adv Med Imaging Sci Boston MA 02114 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Pathol &

    Lab Med Los Angeles CA 90095 USA;

    Univ Calif Los Angeles Dept Microbiol Immunol &

    Mol Genet Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Hlth Network Princess Margaret Canc Ctr Immune Therapy Program Toronto ON M5G 2M9 Canada;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Div Hematol Oncol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Human Genet Los Angeles CA 90095 USA;

    Univ Washington Dept Immunol Seattle WA 98109 USA;

    Univ Calif Los Angeles David Geffen Sch Med Dept Mol &

    Med Pharmacol Los Angeles CA 90095 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 细胞生物学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号